Preclinical

App taps into patient data to explore human side of cancer

10-Mar-2022 By Jenni Spinner

Patient-centric company Belong.life has developed an app designed to inform cancer research by offering a holistic view of the lives of people with cancer.

Sanofi US forms digital therapeutics partnership with DarioHealth

08-Mar-2022 By Jenni Spinner

The pharmaceutical company and the digital therapeutics specialist are joining forces to help accelerate the expansion of various digital health solutions.

Pfizer, CytoReason extend AI pact after immune system success

08-Mar-2022 By Nick Taylor

The drug company has renewed its arrangement with the artificial intelligence specialist, centered on using AI to improve understanding of the immune system.

Boehringer Ingelheim, Lifebit team up to build data platform

07-Mar-2022 By Jenni Spinner

The pharma firm has allied with the biotech to create a scalable data, analytics, and infrastructure platform to generate insights from healthcare biobanks.

Stanford laboratory aligns with Pepper Bio to target tough cancers

03-Mar-2022 By Jenni Spinner

The drug discovery firm will work with the Dean Felsher Laboratory, using the company’s transomics platform to discover therapies for untreatable cancers.

People on the Move: March 2022

03-Mar-2022 By Jenni Spinner

This month’s announcements include hiring, expansion, and acquisition news from companies like DFE Pharma, ClinOne, Novartis, LEGO, Benchling, and more.

rare disease day

Rare diseases, very special patients highlighted in event

28-Feb-2022 By Jenni Spinner

The recent Outsourcing-Pharma webinar hosted a trio of industry experts highlighting challenges, opportunities, and innovations in the rare disease realm.

rare disease day 2022

Rare disease research center to use Trialbee recruitment tech

28-Feb-2022 By Jenni Spinner

Ergomed, a global contract research organization, is partnering with Trialbee to improve patient recruitment at its new Rare Disease Innovation Center.

rare disease day 2022

Genomenon forges rare-disease partnership with advocacy group

24-Feb-2022 By Jenni Spinner

The AI-centered genomics company is joining with Don’t Forget Morgan, a group for patients with BPAN, to explore treatments for the neurodegenerative condition.

rare disease day 2022

Lilly planning $700m genetic medicine development center

24-Feb-2022 By Jenni Spinner

The pharmaceutical company’s Lilly Institute for Genetic Medicine reportedly will focus on developing RNA-based therapeutics in a ‘state-of-the-art’ facility.

Emmes contributes data service to pediatric COVID-19 research

21-Feb-2022 By Jenni Spinner

The CRO is helping out on a project exploring the effects of the virus in children; other members of the research team include experts from Duke University.

For rare disease patients, ‘every day is Rare Disease Day’

21-Feb-2022 By Jenni Spinner

On February 23, five days ahead of the day of rare-disease awareness, OSP’s Rare and Orphan Diseases webinar will share insights from top industry experts.

Tech Innovations: February 2022

17-Feb-2022 By Jenni Spinner

This month’s list of announcements about technology, funding, and more includes Medable, Clarify Health, Thermo Fisher Scientific, and other key companies.

Domainex, Parkinson’s UK team up to advance neuroinflammation program

15-Feb-2022 By Nick Taylor

The institute and the research/support organization will collaborate on development of novel therapies aimed at treating the central nervous system disorder.

Clinical research trends include increased emphasis on study design: Advarra

15-Feb-2022 By Jenni Spinner

An expert from the institutional review board services company advises what trends to look for in the clinical trial industry over the course of coming months.

Collaboration to advance development of cancer therapies

14-Feb-2022 By Jenni Spinner

Cullinan Oncology has formed a strategic partnership with the Icahn School of Medicine at Mount Sinai to research and develop targeted therapies for cancer.

Merck restructures to strengthen CDMO business

14-Feb-2022 By Jane Byrne

Darmstadt, Germany headquartered, Merck KGaA, is restructuring its life sciences business.

Online event to address disparities in cancer research, care

08-Feb-2022 By Jenni Spinner

The latest in the Diversity in Oncology series, taking place February 9, will discuss ways academia and community collaboration can narrow representation gaps.

AI can be a powerful tool in drug development, discovery: Tellius

03-Feb-2022 By Jenni Spinner

A leader from the artificial intelligence insights specialist talks discusses how the effective use of advanced analytics can lead to a number of benefits.

WORLD CANCER DAY

Memorial Sloan Kettering announces $100m gift for cancer research

03-Feb-2022 By Jenni Spinner

The oncology center’s Marie-Josée and Henry R. Kravis Cancer Ecosystems Project is intended to elevate the next generation of preclinical cancer research.

People on the Move: February 2022

03-Feb-2022 By Jenni Spinner

This month’s announcements include new hires, promotions, acquisitions, and other events from Saama, Javara, Firma, GlaxoSmithKline, and other companies.

WORLD CANCER DAY

Global campaign aims to increase equity in cancer care

01-Feb-2022 By Jenni Spinner

On World Cancer Day, the Union for International Cancer Control is launching a three-year campaign with the goal to improve cancer care around the globe.

UK research hub launched to tackle rare kidney disease

31-Jan-2022 By Jenni Spinner

The Stoneygate and Kidney Research UK Alport Research Hub aims to accelerate research and develop treatments for Alport syndrome, a rare genetic disorder.

New FDA draft guidance document gets real about RWD use

28-Jan-2022 By Jenni Spinner

A representative from IQVIA discusses the particulars of the US agency’s new draft document and shares what it might mean for clinical trial data evaluation.

SCOPE 2022

Time to change thinking around patient recruitment: Elligo

26-Jan-2022 By Jenni Spinner

A leader from Elligo Health Research (a SCOPE 2022 exhibitor ) discusses flaws in traditional recruitment approaches and offers up some fresh new ideas.

SCOPE 2022

Bright ideas, new partnerships, and fun on tap at SCOPE 2022

26-Jan-2022 By Jenni Spinner

The upcoming industry event offers attendees (in-person and virtual) a range of opportunities to learn, connect, and innovate, according to an organizer.

SCOPE 2022

SCOPE award salutes heroic innovation in clinical trial solutions

26-Jan-2022 By Jenni Spinner

One of the finalists for the 2022 Participant Engagement Award (saluting patient recruitment and retention solution) will be announced as winner at SCOPE.

Charles River joins with immunology lab on COVID-19 research

24-Jan-2022 By Jenni Spinner

The CRO's work with La Jolla Institute for Immunology, centered on a unique mouse model, is intended to increase understanding of how the COVID-19 virus operates.

Will new Facebook ad policy shake up clinical trial recruitment?

20-Jan-2022 By Jenni Spinner

An expert from patient solutions firm Trialbee discusses how the social media firm's recent ban on targeted advertising might impact patient recruitment.

Pfizer: COVID-19 treatment shows promise against omicron variant

18-Jan-2022 By Jenni Spinner

The pharmaceutical company reports studies have demonstrated the main protease inhibitor of Paxlovid maintains in vitro efficiency against the variant.

Vanderbilt discovery offers hope for colorectal cancer patients

17-Jan-2022 By Jenni Spinner

The researchers, in studying how polyps morph into colorectal cancer, have set a path for improved surveillance of the disease, harnessing precision medicine.

Pharma R&D investment report shows positive signs: Deloitte

14-Jan-2022 By Jenni Spinner

According to the company’s 12th Annual Pharmaceutical Innovation Report, pharmaceutical R&D return on investment has climbed to its highest peak since 2014.

Managing QC lab data is important part of research equation: Veeva

13-Jan-2022 By Jenni Spinner

A leader from the company discusses challenges in control labs and shares how a new solution aims to clear some key obstacles to greater effectiveness.

Sanofi extends its RWD-focused partnership with Evidation

10-Jan-2022 By Jenni Spinner

The collaboration will center on development of unique data sets, which could be used in helping promote better understanding of aspects of human health.

Stand Up To Cancer research initiative targets pancreatic cancer

10-Jan-2022 By Jenni Spinner

Joining with a noted research foundation, the group is aiming for earlier detection and treatment of the disease, which hits nearly 500K people annually.

People on the Move: January 2022

06-Jan-2022 By Jenni Spinner

This month’s news on mergers and acquisitions, hires, and other developments includes notable firms like Altasciences, Protocol First, WuXi STA, and more.

Clover Biopharmaceuticals begins construction of new R&D center in Shanghai

06-Jan-2022 By Rachel Arthur

Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.

Artificial intelligence could benefit all aspects of clinical trials: IQVIA

04-Jan-2022 By Jenni Spinner

An AI expert discusses progress in the field, gaps in understanding, and how predictive modeling and other advanced analytical tools could be put to use.

Purchases, pandemic, and potential treatments: 2021’s greatest hits

22-Dec-2021 By Jenni Spinner

OSP’s list of the year’s most-read stories shows readers are interested in M&A activities, new drug candidates, COVID-19 developments, and other hot news.

Bias in artificial intelligence impacts drug development: AiCure

20-Dec-2021 By Jenni Spinner

According to an expert from the clinical insights company, prejudice in AI can impact patient outcomes as well as the ability to develop effective treatments.

Most oncologists think RWD vital to advancing cancer research: COTA

17-Dec-2021 By Jenni Spinner

The company has released a survey of cancer doctors; 83% of those polled believe real-world data is crucial to accelerating cancer research and treatment.

Abbott, Howard University join to boost research diversity

13-Dec-2021 By Jenni Spinner

The healthcare company has gifted $1m to form a scholarship fund for students headed toward careers in clinical research, with the aim of increasing diversity.

Time to take trial data analysis to the next level: ConcertAI

09-Dec-2021 By Jenni Spinner

A leader from the advanced data and artificial intelligence specialist suggests ways to advance data collection through new tools, techniques, and thinking.

Roquette plans to open doors of new US innovation center

08-Dec-2021 By Jenni Spinner

Sited in Pennsylvania, the excipients specialist’s new facility reportedly will work toward advancing drug delivery research and boosting speed to market.

Is artificial intelligence the best tool for drug discovery?

07-Dec-2021 By Jenni Spinner

According to a leader from Cytoreason, AI isn’t necessarily the best or only tool suited to discover new and novel therapies—it might take a human touch.

People on the Move: December 2021

02-Dec-2021 By Jenni Spinner

This month’s announcements of awards, expansions, name changes, hires, and other news includes items from CPhI, Almac Group, ICON, and other organizations.

GSK and University of Oxford launch new institute, embracing advanced technologies for drug discovery

02-Dec-2021 By Rachel Arthur

The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.

Gain Therapeutics presents hopeful data for Parkinson’s, Gaucher treatment

29-Nov-2021 By Jenni Spinner

The biotech firm has presented data from a study that could offer hope to patients with Parkinson’s, Gaucher, Alzheimer’s and other neurodegenerative conditions.

Genetic testing offers powerful weapon for detecting breast cancer: Sema4

29-Nov-2021 By Jenni Spinner

A leader from Sema4, the health intelligence company, explains how progress in genetic testing has helped advance breast cancer detection and prevention.

Mix-and-match COVID-19 vaccines: New trial to add to growing body of research

25-Nov-2021 By Rachel Arthur

A new clinical trial of heterologous – or ‘mix-and-match’ – combinations of COVID-19 vaccines is set to start in Pakistan: seeking to add to research on the effectiveness of such combinations.